+39.1%
MRNA vs KVYO
-55.5%
+94.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | KVYO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.4% | +4.0% | +5.1% |
| 7D | -1.1% | -12.1% | +11.0% | +1.1% |
| 30D | +126.1% | -5.2% | +131.3% | +127.9% |
| 3M | +190.0% | +14.5% | +175.5% | +183.2% |
| 6M | +157.2% | -17.6% | +174.9% | +156.1% |
| YTD | +388.2% | -49.6% | +437.8% | +434.2% |
| 1Y | +467.0% | -48.6% | +515.6% | +514.0% |
| All | +39.1% | -55.5% | +94.5% | +44.4% |
Cumulative growth
Daily Returns
Daily percentage return beside KVYO.
Daily Out/Under-Performance
Portfolio return minus KVYO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KVYO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded KVYO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling